Thomas McCauley
Chief Tech/Sci/R&D Officer bei OMEGA THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Profil
Thomas McCauley is currently the Chief Scientific Officer at Omega Therapeutics, Inc. Prior to this, he held the same position at Zikani Therapeutics, Inc. from 2018 to 2019 and at Translate Bio, Inc. from 2016 to 2018.
He was also the Vice President at Shire Pharmaceuticals, Inc. from 2010 to 2016.
McCauley received his undergraduate degree from Cornell University and his doctorate from The University of Alabama at Birmingham.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OMEGA THERAPEUTICS, INC.
-.--% | 07.02.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Thomas McCauley
| Unternehmen | Position | Beginn |
|---|---|---|
| OMEGA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.07.2019 |
Ehemalige bekannte Positionen von Thomas McCauley
| Unternehmen | Position | Ende |
|---|---|---|
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | Corporate Officer/Principal | 01.07.2019 |
| TRANSLATE BIO, INC. | Corporate Officer/Principal | 01.04.2018 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 01.08.2016 |
Ausbildung von Thomas McCauley
| Cornell University | Undergraduate Degree |
| The University of Alabama at Birmingham | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OMEGA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
Zikani Therapeutics, Inc.
Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | Retail Trade |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
